| 中文名 | 康力龙 |
| 英文名 | Stanozolol |
| 别名 | 康九龙 康力龙 司坦唑醇 醋酸孕诺酮 康力龙(微粉) 吡唑甲基睾丸素 康立龙(司坦唑醇) 康力龙,吡唑甲氢龙,吡唑甲基睾丸素 康立龙(司坦唑醇)溶液, 1000PPM |
| 英文别名 | Stanzolol Stanazolol Stanozolol Winstrol l ndrostanazol Stanozolol CIII (200 mg) Stanozolol(Winstrol, Winstrol Depot) Stanozolol Suspension (For Injection) 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole 2-c)pyrazol-17beta-ol,17-methyl-2'h-5alpha-androst-2-eno( 17-alpha-methyl-5-alpha-androstano(3,2-c)pyrazol-17-beta-ol 2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl- 2-c)pyrazol-17-ol,17-methyl-,(5alpha,17beta)-2'h-androst-2-eno( 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)- 1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol |
| CAS | 10418-03-8 |
| EINECS | 233-894-8 |
| 化学式 | C21H32N2O |
| 分子量 | 328.49 |
| InChI | InChI=1/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
| InChIKey | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
| 密度 | 1.129±0.06 g/cm3(Predicted) |
| 熔点 | 242 °C |
| 沸点 | 490.8±45.0 °C(Predicted) |
| 比旋光度 | 34 º |
| 闪点 | -2℃ |
| 蒸汽压 | 1.89E-10mmHg at 25°C |
| 溶解度 | Practically insoluble in water, soluble in dimethylformamide, slightly soluble in ethanol (96 per cent), very slightly soluble in methylene chloride. |
| 折射率 | 34 ° (C=0.4, CHCl3) |
| 酸度系数 | 15.15±0.60(Predicted) |
| 存储条件 | 2-8°C |
| 外观 | powder |
| 颜色 | white to light yellow |
| Merck | 8794 |
| 物化性质 | 比旋光度 34° |
| 产品用途 | 用于慢性消耗性疾病、重病及手术后体弱消瘦、年老体弱、骨质疏松症、小儿发育不良、再生障碍性贫血等 |